Why does null hypothesis testing matter for fibrosis marker validation?

Null hypothesis testing using this model enables objective evaluation of whether observed changes in fibrosis markers, such as collagen and alpha smooth muscle actin, are statistically significant compared to controls. This supports rigorous target validation and reduces the risk of false-positive findings in early discovery.

How does independent variable isolation fit the electrocoagulation workflow?

The protocol isolates the effect of electrocoagulation on the pancreatic duct, allowing researchers to attribute downstream biochemical and histological changes specifically to this intervention. This clarity is critical for mechanistic studies and for evaluating candidate therapeutic interventions.

What do quantitative serum amylase and bilirubin measurements enable?

Quantitative measurement of serum amylase and bilirubin provides objective biomarkers for disease severity and progression, enabling comparative analysis across experimental groups and supporting data-driven advancement decisions.

Why are replication requirements important for cross-functional collaboration?

Standardized and replicable model outputs, such as fibrosis scoring and serum biomarker levels, facilitate data sharing and interpretation across discovery, translational, and preclinical teams, ensuring alignment and reproducibility in multi-site research programs.

What statistical analysis capabilities are required before implementing fibrosis quantification?

Robust statistical analysis, including group comparisons and significance testing of fibrosis and biomarker data, is essential to validate findings and support decision-making for target prioritization and therapeutic evaluation in the biopharma pipeline.

Модель обструктивного хронического панкреатита, установленная с помощью электрокоагуляции

763 просмотров

06:28 мин

31 октября 2025 г.

10.3791/67061-v

31 октября 2025 г.

763 просмотров

Zhenghui Yang^*¹^,² , Wanshun Li^*¹^,²^,³ , Jiayu Li^*¹^,²^,³ , Yuyan Zhou¹^,² , Chang Wu¹^,² , Yue Liu¹^,² , Xinyue Wang¹^,² , Dongling Wan¹^,² , Yi Lu¹^,²^,³ , Yihai Shi⁴ , Huanhai Xu⁵ , Zhendong Jin¹^,² , Deyu Zhang¹^,² , Haojie Huang¹^,²

¹Department of Gastroenterology, Changhai Hospital, Naval Medical University, ²National Key Laboratory of Immunity and Inflammation, Naval Medical University, ³College of Basic Medical Science, Naval Medical University, ⁴Department of Gastroenterology, Shanghai Pudong New Area Gongli Hospital Shanghai, ⁵Department of Gastroenterology. Affiliated Yueqing Hospital, Wenzhou Medical University

^* These authors contributed equally

Настоящий протокол описывает новый подход к моделированию хронического обструктивного панкреатита, который включает в себя визуализацию протока поджелудочной железы и электрокоагуляцию протока поджелудочной железы для вызова обструкции протока поджелудочной железы.